Willy Rozenbaum | Academic Influence

Willy Rozenbaum's AcademicInfluence.com Rankings

Willy Rozenbaum

Philosophy

#10631

World Rank

#14585

Historical Rank

Logic

#7499

World Rank

#9280

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Willy Rozenbaum's Degrees

Doctorate Medicine Université Paris Cité

Why Is Willy Rozenbaum Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Willy Rozenbaum is a Polish-born French physician. A co-discoverer of the human immunodeficiency virus with Jean-Claude Chermann of Luc Montagnier's team, he has since 19 November 2003 held the chair of France's "conseil national du SIDA" and before that had since 1989 practiced in the infectious and tropical diseases service at l'Hôpital Tenonfr and been professor of infectious and tropical diseases at l'Hôpital Saint-Antoine in Paris.

(See a Problem?)

Willy Rozenbaum's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). (1983) (6417)
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. (2015) (1182)
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). 1983. (2004) (519)
Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance (2002) (420)
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. (2001) (363)
AIDS subacute encephalitis. Identification of HIV-infected cells. (1987) (293)
Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy. (2002) (266)
Comparison of Once-Daily Atazanavir With Efavirenz, Each in Combination With Fixed-Dose Zidovudine and Lamivudine, As Initial Therapy for Patients Infected With HIV (2004) (258)
DETECTION OF IgG ANTIBODIES TO LYMPHADENOPATHY-ASSOCIATED VIRUS IN PATIENTS WITH AIDS OR LYMPHADENOPATHY SYNDROME (1984) (228)
Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy (2003) (208)
Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART). (1999) (205)
Anti‐hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV‐infected patients (2006) (178)
EFFECTS OF ZIDOVUDINE IN 365 CONSECUTIVE PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX (1988) (171)
Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA (2001) (167)
Altered Fat Differentiation and Adipocytokine Expression are Inter-Related and Linked to Morphological Changes and Insulin Resistance in HIV-1-Infected Lipodystrophic Patients (2003) (165)
Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome. (1991) (163)
Sensitivity of Five Rapid HIV Tests on Oral Fluid or Finger-Stick Whole Blood: A Real-Time Comparison in a Healthcare Setting (2010) (159)
BMD Is Reduced in HIV‐Infected Men Irrespective of Treatment (2003) (150)
ANTIMONIOTUNGSTATE (HPA 23) TREATMENT OF THREE PATIENTS WITH AIDS AND ONE WITH PRODROME (1985) (150)
Quantification of Human Immunodeficiency Virus Type 1 Proviral Load by a TaqMan Real-Time PCR Assay (2001) (148)
T cell receptor gamma/delta+ lymphocyte subsets during HIV infection. (1989) (148)
Quantitative Analysis of Human Herpesvirus 8 Viral Load Using a Real-Time PCR Assay (2000) (142)
Reversible ALS-like disorder in HIV infection (2001) (137)
Intravenous methotrexate for primary central nervous system non‐Hodgkin's lymphoma in AIDS (1997) (128)
Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients. (2000) (122)
Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS. (1995) (121)
Evidence for Changes in Adrenal and Testicular Steroids During HIV Infection (1992) (116)
Long-Term Efficacy and Safety of Atazanavir With Stavudine and Lamivudine in Patients Previously Treated With Nelfinavir or Atazanavir (2004) (111)
Adverse metabolic disorders during highly active antiretroviral treatments (HAART) of HIV disease. (1999) (109)
Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome. (1989) (105)
Autoantibodies to Phospholipids and to the Coagulation Proteins in AIDS (1997) (99)
HIV TRANSMISSION BY ORAL SEX (1988) (85)
Reduction in Triglyceride Level With N-3 Polyunsaturated Fatty Acids in HIV-Infected Patients Taking Potent Antiretroviral Therapy: A Randomized Prospective Study (2007) (83)
The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS‐related complex: a double‐blind, randomized trial (1993) (83)
Sexual dysfunction in 156 ambulatory HIV-infected men receiving highly active antiretroviral therapy combinations with and without protease inhibitors. (2002) (79)
Effect of Pioglitazone on HIV-1-Related Lipodystrophy: A Randomized Double-Blind Placebo-Controlled Trial (ANRS 113) (2008) (78)
Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HIV-1-infected adults with viral suppression receiving a protease inhibitor-based regimen: a randomized trial. (2005) (70)
Quantification of Epstein‐Barr virus load in peripheral blood of human immunodeficiency virus‐infected patients using real‐time PCR (2001) (69)
Phylogenetic Analyses Indicate an Atypical Nurse-to-Patient Transmission of Human Immunodeficiency Virus Type 1 (2000) (68)
Diagnosis, and prognosis of AIDS‐related cholangitis (1995) (65)
Thrombotic microangiopathy and cytomegalovirus disease in patients infected with human immunodeficiency virus. (1997) (59)
Comparison among acquired immune deficiency syndrome patients with and without clinical evidence of cardiac disease. (1988) (58)
Isolation of a new retrovirus in a patient at risk for acquired immunodeficiency syndrome. (1983) (58)
ACQUIRED IMMUNODEFICIENCY SYNDROME IN FRANCE (1983) (57)
Definition and diagnosis of cytomegalovirus colitis in patients infected by human immunodeficiency virus. (1997) (55)
[Piercing and its infectious complications. A public health issue in France]. (2000) (55)
Detection of human Betaherpesvirinae in saliva and urine from immunocompromised and immunocompetent subjects (1997) (55)
Effect of indinavir on HIV‐related wasting (1998) (55)
Cytomegalovirus multifocal neuropathy in AIDS (1994) (55)
Cutaneous Local Necrosis Following Interferon Injections (1991) (54)
Etiology and management of toxic megacolon in patients with human immunodeficiency virus infection. (1994) (54)
Cholangiopathy associated with Microsporidia infection of the common bile duct mucosa in a patient with HIV infection. (1992) (54)
Antiretroviral therapy in public and private routine health care clinics in Cameroon: lessons from the Douala antiretroviral (DARVIR) initiative. (2005) (53)
Human immunodeficiency virus and infected aneurysm of the abdominal aorta: Report of three cases (1992) (51)
The Virgo Study: Nevirapine, Didanosine and Stavudine Combination Therapy in Antiretroviral-Naive HIV-1-Infected Adults (1999) (49)
High Variability of Plasma Drug Concentrations in Dual Protease Inhibitor Regimens (2003) (48)
Filgrastim to treat neutropenia and support myelosuppressive medication dosing in HIV infection (1996) (47)
Results of chemotherapy in 30 AIDS patients with symptomatic pulmonary Kaposi's sarcoma. (1994) (47)
Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients (2007) (45)
Splenic infarction during acute malaria. (2005) (43)
The clinical characteristics of HIV-infected patients receiving dialysis in France between 1997 and 2002. (2005) (42)
Acute renal failure induced by foscarnet: 4 cases. (1988) (41)
Correction of facial lipoatrophy in HIV-infected patients on highly active antiretroviral therapy by injection of autologous fatty tissue. (2002) (41)
Macronutrient intake and malabsorption in HIV infection: a comparison with other malabsorptive states (1997) (40)
Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patients with HIV infection. (1987) (39)
Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS‐associated mucocutaneous Kaposi's sarcoma (1996) (39)
A Meta-Analysis of Six Placebo-Controlled Trials of Thiazolidinedione Therapy for HIV Lipoatrophy (2010) (37)
MULTIPLE OPPORTUNISTIC INFECTION IN A MALE HOMOSEXUAL IN FRANCE (1982) (36)
Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once‐daily for the treatment of HIV‐infected adults (pharmacokinetic substudy of the ANRS 091 trial) * (2004) (35)
Long-term follow-up of 120 patients with AIDS-related Kaposi's sarcoma treated with interferon alpha-2a. (1990) (34)
N-acetylation genotype and risk of severe reactions to sulphonamides in AIDS patients. (1994) (33)
Daily or on-demand oral tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis: experience from a hospital-based clinic in France. (2018) (33)
Is there correlation of T cell proliferative functions and surface marker phenotypes in patients with acquired immune deficiency syndrome or lymphadenopathy syndrome? (1985) (31)
Rifabutin in combination with clofazimine, isoniazid and ethambutol in the treatment of AIDS patients with infections due to opportunist mycobacteria. Groupe d'Etude et de Traitement des Infections à Mycobacteries Résistantes. (1991) (30)
Cytomegalovirus-induced alveolar hemorrhage in patients with AIDS: a new clinical entity? (1996) (29)
Factors of weight loss in patients with HIV and chronic diarrhea. (1998) (28)
Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study. (1996) (28)
Treatment interruption after one year of triple nucleoside analogue therapy for primary HIV infection. (2001) (27)
Interferon beta transduction of peripheral blood lymphocytes from HIV-infected donors increases Th1-type cytokine production and improves the proliferative response to recall antigens. (1997) (27)
Immunological Responses and Long-Term Treatment Interruption after Human Immunodeficiency Virus Type 1 (HIV-1) Lipopeptide Immunization of HIV-1-Infected Patients: the LIPTHERA Study (2008) (26)
Critical analysis of T cell subset and function evaluation in patients with persistent generalized lymphadenopathy in groups at risk for AIDS. (1984) (26)
Differences in androgens of HIV positive patients with and without Kaposi sarcoma. (1995) (25)
Ribavirin therapy for adenovirus pneumonia in an AIDS patient. (1997) (24)
Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor‐sparing therapy in patients with lipoatrophy: results from the 96‐week randomized ANRS 108 NoNuke Trial (2008) (24)
Proposed World-Health-Organization Staging System for Hiv-Infection and Disease - Preliminary Testing by An International Collaborative Cross-Sectional Study (1992) (24)
Lenograstim for the treatment of neutropenia in patients receiving ganciclovir for cytomegalovirus infection: a randomised, placebo‐controlled trial in AIDS patients (2000) (23)
Challenges and opportunities for oral pre-exposure prophylaxis in the prevention of HIV infection: where are we in Europe? (2013) (23)
A highly virulent variant of HIV-1 circulating in the Netherlands (2022) (23)
Diversity of the V3 region of HIV in Paris, France (1993) (22)
Multiple myeloma in an HIV-positive man presenting with primary cutaneous plasmacytomas and spinal cord compression. (1998) (21)
Early Impairment of CD8+ T Cells Immune Response Against Epstein–Barr Virus (EBV) Antigens Associated with High Level of Circulating Mononuclear EBV DNA Load in HIV Infection (2004) (20)
Production of HIV-1 by human B cells infected in vitro: characterization of an EBV genome-negative B cell line chronically synthetizing a low level of HIV-1 after infection. (1998) (18)
Monitoring of antibodies against human immunodeficiency virus type 1 p25 core protein as prognostic marker. (1992) (18)
Long-Term Outcome and Treatment Modifications in a Prospective Cohort of Human Immunodeficiency Virus Type 1-Infected Patients on Triple-Drug Antiretroviral Regimens (2000) (18)
[Neuropathological study of 31 cases of acquired immunodeficiency syndrome]. (1987) (18)
HIV transmission by oral sex [letter] (1988) (18)
Autocrine interferon-β synthesis for gene therapy of HIV infection: increased resistance to HIV‐1 in lymphocytes from healthy, and HIV‐infected individuals (1995) (17)
Lymphadenopathy in patients at risk for acquired immunodeficiency syndrome. Histopathology and histochemistry. (1985) (17)
First-line Highly Active Antiretroviral Regimens in 2001–2002 in the French Hospital Database on HIV: Combination Prescribed and Biological Outcomes (2006) (17)
Emergence of HIV-1 mutated strains after interruption of highly active antiretroviral therapy in chronically infected patients (2003) (16)
Cutaneous Lesions Due to Acanthamoeba sp in a Patient with AIDS (1996) (16)
Two cases of cytomegalovirus infection revealed by hearing loss in HIV-infected patients. (1997) (16)
HIV-1 related ischaemic trochlear nerve palsy (2003) (15)
Daily or on demand oral TDF/FTC for HIV pre-exposure prophylaxis: experience from an hospital-based clinic in France. (2018) (15)
Abnormal in vitro proliferation and differentiation of T colony forming cells in AIDS patients and clinically normal male homosexuals. (1985) (15)
Glutathione S-transferase (GSTM1) null genotype and sulphonamide intolerance in acquired immunodeficiency syndrome. (1997) (14)
Rate of detection of human herpesvirus-6 at different stages of HIV infection (1995) (12)
Efficacy and Safety of a Switch to Rilpivirine-Based Regimens in Treatment-Experienced HIV-1-Infected Patients: A Cohort Study (2015) (11)
HIV AND OROGENITAL TRANSMISSION (1988) (11)
Peptide insertions in reverse transcriptase pol gene of human immunodeficiency virus type 1 as a rare cause of persistent antiretroviral therapeutic failure. (2004) (11)
Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS. (1989) (11)
Factors predictive of disease progression and death in AIDS‐related Kaposi's sarcoma (2000) (11)
Results of culture form colonoscopically obtained specimens for bacteria and fungi in HIV-infected patients with diarrhea. (1996) (11)
HIV-1-related spontaneous episodic hypothermia (2003) (11)
Vitamin B12 injections in patients treated with zidovudine. (1990) (10)
[Decrease of erythrocyte receptors for the C3b fragment of complement in acquired immunodeficiency syndrome]. (1988) (10)
Treatment Intensification with Abacavir in HIV-Infected Patients with at Least 12 Weeks Previous Lamivudine/Zidovudine Treatment (2000) (9)
Pericardial effusion and AIDS: benefits of surgical drainage. (1998) (9)
[Lymphomas and AIDS]. (1986) (9)
Rifabutin versus placebo in combination with three drugs in the treatment of nontuberculous mycobacterial infection in patients with AIDS. (1996) (9)
[A cost-effectiveness analysis of changes in therapeutic strategies in the treatment of HIV since 1996]. (2002) (8)
The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative Group. (1993) (8)
Intestinal histoplasmosis in AIDS patients: report of three cases observed in France and review of the literature. (1995) (8)
Abnormal in vitro proliferation and differentiation of T colony-forming cells in patients with lymphadenopathy syndrome. (1986) (7)
[Lactic acidosis in HIV infected patients]. (1994) (7)
Lopinavir/r no longer recommended as a first-line regimen: a comparative effectiveness analysis (2014) (7)
Tissue-type plasminogen activator activity in HIV-associated HUS. (1998) (7)
Clinical and bacteriologic impact of rifabutin prophylaxis for Mycobacterium avium complex infection in patients with human immunodeficiency virus infection. (1997) (7)
French HIV Experts on Early Antiretroviral Treatment for Prevention (2014) (7)
IMMUNE STATUS OF AIDS PATIENTS IN FRANCE: RELATIONSHIP WITH LYMPHADENOPATHY ASSOCIATED VIRUS TROPISM a (1984) (6)
Treatment of non-meningeal cryptococcosis in patients with AIDS. Centre d'Informations et de Soins de l'Immunodéficience Humaine de l'Est Parisien. (1996) (6)
Histoplasmose à Histoplasma capsulatum et sida (1995) (6)
Stavudine plus didanosine and nevirapine in antiretroviral-naive HIV-infected adults: preliminary safety and efficacy results. VIRGO Study Team. (1998) (6)
Use of well-defined HIV-derived epitopes to evaluate CD4(+) and CD8(+) T cell responses in patients with chronic HIV-1 infection treated with HAART. (2004) (6)
Outbreak of syphilis among HIV-infected patients: descriptive data from a Parisian hospital. (2005) (6)
Does region of origin influence the timing and outcome of first‐line antiretroviral therapy in France? (2018) (5)
Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Trial (2018) (5)
Minimal interference: A basis for selecting ART for prevention with positives (2013) (5)
Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Trial (2018) (5)
Clinical and laboratory findings of disseminated Mycobacterium avium complex infection (DMAC) in a pair matched case-control study. (1999) (5)
[Acquired immunodeficiency syndrome in 4 homosexuals]. (1983) (5)
Intestinal microsporidiosis: about clinical characteristics and laboratory diagnosis. (1994) (5)
Changes in Sexual Behaviors in Men Who Have Sex with Men: A Comparison Between the Double-Blind and Open-Label Extension Phases of the ANRS-IPERGAY Trial (2020) (5)
Mortality of people living with HIV in Paris Area from 2011 to 2015. (2020) (5)
HIV-related diarrhea : Efficacy of acetorphan in a randomized controlled trial (1995) (5)
Prospective follow-up of 67 indinavir-experienced human immunodeficiency virus-infected and AIDS patients treated with the ritonavir/saquinavir combination. (1999) (4)
Long-term outcome and treatment modifications in a prospective cohort of human immunodeficiency virus type 1-infected patients on triple-drug antiretroviral regimens. Triest Cohort Investigators. (2000) (4)
[Lesions of the conus medullaris and the cauda equina caused by cytomegalovirus in HIV infection. 7 cases]. (1995) (4)
Cerebral toxoplasmosis in AIDS: a simple laboratory technique for diagnosis. (1984) (4)
[Zidovudine efficacy and tolerance in 32 patients with cerebral toxoplasmosis in the acquired immunodeficiency syndrome]. (1988) (4)
Efficacy and safety of rilpivirine-based regimens in treatment-experienced HIV-1 infected patients: a prospective cohort study (2014) (4)
[Parasitic and fungal diseases in AIDS (excluding pneumocystosis)]. (1986) (4)
Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patients. (1999) (4)
Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
Interferon b transduction of peripheral blood lymphocytes from HIV-infected donors increases Th1-type cytokine production and improves the proliferative response to recall antigens (gene therapyyretroviral vectoryhuman CD41 cellsyimmunology) (1997) (3)
[Liver toxicity of antiretroviral treatments]. (2003) (3)
Prognostic value of blood and bone marrow T-colony-forming cells (T-CFC) in patients with lymphadenopathy syndrome (LAS). (1988) (3)
Manifestations maxillo-faciales du syndrome d'immuno-dépression acquise (1985) (3)
[Febrile pseudotumor lesion of the arm. Atypical presentation of Shulman syndrome]]. (2003) (3)
Primary cardiac lymphoma in patients with AIDS. (1995) (3)
[Hemolytic jaundice related to ingestion of indinavir]. (1997) (3)
Effect of interferon alpha on high serum androgen concentrations in HIV positive men with Kaposi's sarcoma. (1997) (3)
Possible correlation between exposure to aids risk factors, clinical presentation in aids, and subsequent prognosis (1989) (3)
Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial). (2011) (3)
[Hepatic necrosis secondary to tienilic acid therapy (author's transl)]. (1980) (3)
Antiretroviral Therapy Initiation in France (2012) (2)
What is a modest public health impact? (2012) (2)
[Anasarca caused by exudative enteropathy due to digestive Kaposi's sarcoma]. (1989) (2)
Effect of interferon on high serum androgen concentrations in HIV positive men with Kaposi's sarcoma (2)
[Human cryptosporidiosis: a propos of 4 cases]. (1984) (2)
[Psychosocial consequences of HIV infection]. (1988) (2)
AIDS and lymphadenopathy syndrome (LAS) patients display similar abnormal in vitro proliferation and differentiation of T-colony forming cells (T-CFC). (1987) (2)
HIV experts on the decision to use early ART for prevention in France: are we there yet? (2012) (2)
[Effect of socio-occupational category on iterative hemodialysis treatment of advanced chronic renal insufficiency. Results of the DIAPHANE computerized Dialysis Registry cooperative program]. (1983) (2)
International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK (2016) (2)
Safety and efficacy of switching to elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate in treatment-experienced people with HIV: a multicenter cohort study (2023) (1)
HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in US women; Postive impact of a randomized controlled trial of the Uthando Lwethu ("Our Love") intervention on rates of couples HIV testing in rural South Africa (2016) (1)
A new insertion in the HIV-1 reverse transcriptase gene inducing major resistance to non-nucleoside reverse transcriptase inhibitors (2005) (1)
P.53 Lack of compensatory hyperphagia in HIV-infectedpatients with malabsorption (1996) (1)
Results ofchemotherapy in30AIDS patients withsymptomatic pulmonary Kaposi's sarcoma (1994) (1)
[Contribution of immunology to the positive and differential diagnosis of the acquired immunodeficiency syndrome. Immunologic mechanisms of the syndrome]. (1984) (1)
Subacute Encephalitis Ident fication of HIV-Infected Cells (1)
[Society of Nephrology, Computer Technology Commission. Dialysis computer program. VI. - Survival and risk factors]. (1979) (1)
Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial (2018) (1)
Track D Social Science, Human Rights and Political Science (2012) (1)
Risk factors for A.I.D.S. among homosexual men in France (1988) (1)
[Acquired immunodeficiency syndrome and related syndromes. Critical analysis of biological tests of cell-mediated immunity]. (1984) (1)
[There will not be an AIDS vaccine]. (2004) (0)
Immunological evaluation of acquired immune deficiency syndrome patients in France: preliminary results. (1983) (0)
Septicémie à salmonelle au cours du syndrome d'immunodépression acquise (1985) (0)
[Opportunistic infections in AIDS: the benefits of an "umbrella strategy." From an interview with Professor Willy Rozenbaum]. (1994) (0)
Etiology and Management of Toxic Megacolon With Human lmmunodeficiency Virus Infection in Patients (1994) (0)
[Maxillofacial manifestations of acquired immunodeficiency syndrome]. (1985) (0)
Mantle cell lymphoma in human immunodeficiency virus‐infected patients (2022) (0)
Production of a tac inhibitory activity by adherent cells of HIV-infected subjects at different clinical stages. (1991) (0)
[Development of an anti-HIV gene therapy based on the antiviral properties of beta interferon]. (1997) (0)
Iconography : Acute renal failure revealing aspergilloma in a patient with AIDS (2008) (0)
[Giant esophageal ulcer in a cytomegalovirus infection in a patient with the acquired immunodeficiency syndrome]. (1985) (0)
Fifth International Conference on AIDS : the Scientific and Social Challenge; symposium; natural history and staging of HIV infection (1989) (0)
[Salmonella septicemia in acquired immunodeficiency syndrome]. (1985) (0)
HIV experts on the decision to use early ART for prevention in France: are we there yet? (2012) (0)
Differences inandrogens ofHIVpositive patients withandwithout Kaposi sarcoma (2011) (0)
International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK (2014) (0)
[Orofacial manifestations of AIDS]. (1986) (0)
[The concept of therapeutic management: exemplary implementation of antiretroviral treatments]. (1998) (0)
[How to lower HIV infection incidence using public health principles]. (2008) (0)
Sunday, 8 July: Posters (2001) (0)
[Kaposi's sarcoma and AIDS]. (1984) (0)
HIV positive men with Kaposi sarcoma trogens in male HIV positive patients with and without Kaposi sarcoma and in HIV negative men (0)
Is lymphocyte transfer a promising therapeutic approach towards AIDS? (1987) (0)
PREDICTIVE FACTORS FOR DISEASE PROGRESSION AND DEATH IN AIDS RELATED KAPOSI'S SARCOMA. (1999) (0)
Risk factors for AIDS among homosexual men in a moderate incidence area. (1987) (0)
[Predictive value of the assay of serum anti-p25 antibodies in patients with human immunodeficiency virus (HIV-1) infection]. (1993) (0)
[Acquired immunodeficiency syndrome "AIDS": limits of the unknown]. (1984) (0)
[AIDS and associated syndromes: clinical manifestations]. (1984) (0)
Etude de differents schemas therapeutiques dans la prophylaxie primaire ou secondaire de la pneumocystose (1990) (0)
Immunodeficiency Virus Type 1 Nurse-to-Patient Transmission of Human Phylogenetic Analyses Indicate an Atypical (2000) (0)
[Teratocarcinoma with pericardial extension in an AIDS patient]. (1994) (0)
Sarcome de Kaposi et S. I. D. A. (1984) (0)
Body composition and mechanisms of weight gain in HIV-infected malnourished patients treated with indinavir (1998) (0)
[Plurifocal alveolar pneumonia in a patient with AIDS: disseminated Mycobacterium avium intracellulare infection with difficult diagnosis]. (1994) (0)
[Risks of transmission of the AIDS virus: preventive approaches in dental medicine]. (1986) (0)
[Clinical examination and principles of the symptomatic treatment of severe infectious diarrhea in the adult]. (1982) (0)
[Adenovirus and acquired immunodeficiency syndrome/Kaposi sarcoma]. (1983) (0)
Compositions Pharmaceutical drug for the treatment of the syndrome of the acquired immunodeficiency syndrome (AIDS) and related (1985) (0)
PIN13: CHANGES IN ANTIRETROVIRAL (ARV) REGIMENS IN CLINICAL PRACTICE: RESULTS FROM THE STAR (SCHEMAS THERAPEUTIQUESANTIRETROVIRAUX) COHORT (2003) (0)
Purified and isolated retrovirus of hiv (1993) (0)
How can industry respond to the AIDS crisis? A case study from Cameroon. (2003) (0)
Effect of indinavir upon body weight of malnourished HIV-infected patients (1998) (0)
Detection and differentiation of Dengue infections with highly sensitive real-time PCRs (2010) (0)
PIN1 PHARMACEUTICAL MANAGEMENT OF NEWLY HIV + DIAGNOSED PATIENTS: RESULTS FROM THE STAR (SCHEMAS THERAPEUTIQUESANTIRETROVIRAUX) COHORT (2003) (0)
PID7: MULTITHERAPIES: TOWARDS COST-SAVING STRATEGIES IN REAL LIFE? (2000) (0)
[Problems raised by the treatment of Kaposi's sarcoma in subjects with AIDS]. (1984) (0)

This paper list is powered by the following services:

Other Resources About Willy Rozenbaum

en.wikipedia.org

What Schools Are Affiliated With Willy Rozenbaum?

Willy Rozenbaum is affiliated with the following schools:

Université Paris Cité

Image Attributions

Image Source for Willy Rozenbaum